Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to $9.9 million.

  • Ascendis Pharma A's Cash from Financing Activities rose 1056504.84% to $9.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $44.3 million, marking a year-over-year decrease of 9091.42%. This contributed to the annual value of $41.1 million for FY2025, which is 9134.57% down from last year.
  • According to the latest figures from Q4 2025, Ascendis Pharma A's Cash from Financing Activities is $9.9 million, which was up 1056504.84% from $45.4 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Cash from Financing Activities ranged from a high of $469.9 million in Q3 2024 and a low of -$23.6 million during Q4 2021
  • For the 5-year period, Ascendis Pharma A's Cash from Financing Activities averaged around $76.9 million, with its median value being $734640.7 (2022).
  • Per our database at Business Quant, Ascendis Pharma A's Cash from Financing Activities soared by 185025495.16% in 2022 and then plummeted by 57335.26% in 2023.
  • Ascendis Pharma A's Cash from Financing Activities (Quarter) stood at -$23.6 million in 2021, then skyrocketed by 105.83% to $1.4 million in 2022, then crashed by 573.35% to -$6.5 million in 2023, then skyrocketed by 101.43% to $92967.8 in 2024, then skyrocketed by 10565.05% to $9.9 million in 2025.
  • Its Cash from Financing Activities was $9.9 million in Q4 2025, compared to $45.4 million in Q3 2025 and $7.9 million in Q2 2025.